Sirius Therapeutics

Sirius Therapeutics is a biotech company in San Diego, United States, founded in 2021. It has raised $210.0M across 3 rounds, most recently a $50.0M Series B in May 2025.

Sirius Therapeutics, Inc.

Employees
51–200
Founded
2021
Business Model
B2B
Total Funding
$210.0M
Last Round
$50.0M Series BMay 2025
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 5 investors for this company. The full record is or through the API.

About

Sirius Therapeutics is a global clinical-stage biotechnology company dedicated to unlocking the clinical and commercial value of siRNA therapeutics, with a goal to transform the current standard of care for chronic diseases. The company develops first-in-class and best-in-class siRNA therapeutics targeting three mega-blockbuster franchises: coagulation disorders, cardiometabolic diseases, and obesity, underpinned by its proprietary PEPR siRNA technology platform. Founded in 2021, Sirius operates a hybrid model with teams in San Diego, USA, and Shanghai, China, combining early development capacity from China with global discovery and regulatory expertise from the U.S.

Summary

It lists 51–200 employees. It has raised $210.0M in total across 3 rounds, most recently a $50.0M Series B round in May 2025. Investors include OrbiMed, Hankang Capital and Creacion Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series BSeries BMay 2025
$50.0M

Sign up to see all 3 events

Funding: Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sirius Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/sirius-therapeutics"><img src="https://indexed.vc/api/badge/company/sirius-therapeutics" alt="Sirius Therapeutics on Indexed.vc" width="260" height="76" /></a>